RAD17 and cancer: The expression levels of LIAS had a positive correlation with the expression levels of CTD-2366F13.1 (R = 0.47, p < 0.001), RAD17 (R = 0.48, p < 0.001), OCIAD1 (R = 0.49, p < 0.001), PACRGL (R = 0.49, p < 0.001), MRPS27 (R = 0.49, p < 0.001), and THAP9 (R = 0.49, p < 0.001) in pan-cancer (Figure 9B).